Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5

Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5

Introduction:Pueraria lobata is traditionally used in China for treatment of non-alcoholic fatty liver disease (NAFLD). Puerarin, a functional drug extracted from Pueraria lobata, features a pharmacological activity. The present study aims to investigate the effect of puerarin intervention on NAFLD....

Full description

Bibliographic Details
Main Authors: Zhaoyi Li, Wenjing Cao, Yuxuan Zhang, Shanglei Lai, Yingyan Ye, Jianfeng Bao, Ai Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Series:Frontiers in Pharmacology
Subjects:
puerarin
non-alcoholic fatty liver disease
FMO5
lipid metabolism
oxidative stress
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1423634/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1423634/full

Similar Items